Clorox Reports 50% Drop in Q4 Earnings as ERP Transition and GOJO Integration Weigh on Results
The consumer products giant posted diluted EPS of $1.34 versus $2.68 year-over-year, with organic sales declining 13% as it laps ERP-related shipments and absorbs acquisition costs.
Challenging Quarter Reflects Operational Transitions
The Clorox Company reported fourth-quarter fiscal 2026 results that underscored the operational complexity of its recent transformation efforts, with diluted earnings per share declining 50% to $1.34 from $2.68 in the year-ago quarter (8-K filing, 2026-08-03). The Oakland-based consumer products company, which completed its acquisition of GOJO Industries in April 2026, faced headwinds from inventory adjustments and system implementation costs.
Net sales decreased 2% to $1.95 billion for the quarter ended June 30, 2026. While the GOJO acquisition—which includes the Purell brand and now operates as Clorox Purell—added approximately 10 percentage points to sales, organic sales declined 13%. The company attributed roughly 13.5 points of this decline to lapping incremental shipments related to its ERP transition in the prior-year quarter (8-K filing, 2026-08-03).
Margin Compression Across the Business
Gross margin contracted 520 basis points to 41.3% from 46.5%, driven by lower volume, the inventory step-up impact from the GOJO acquisition, higher commodity costs, and elevated manufacturing and logistics expenses. Both the ERP-related shipment comparison and the GOJO inventory step-up each reduced gross margin by approximately 150 basis points (8-K filing, 2026-08-03).
Adjusted EPS decreased 42% to $1.66 from $2.87 in the year-ago quarter, with the ERP-related shipment comparison accounting for about 90 cents of the decline (8-K filing, 2026-08-03).
Segment Performance Varied Widely
The Health and Wellness segment, now including Clorox Purell, saw net sales increase 16%, with the GOJO acquisition contributing approximately 28 percentage points. However, organic sales declined 12%, again reflecting the ERP transition impact. Segment adjusted EBIT decreased 15% (8-K filing, 2026-08-03).
The Household segment experienced an 18% sales decline, with volume down 16 points, while segment adjusted EBIT fell 56%. The Lifestyle segment posted a 17% sales decrease and a 60% drop in adjusted EBIT. Only the International segment showed resilience, with sales up 4% and adjusted EBIT increasing 17% (8-K filing, 2026-08-03).
Full-Year Results and Forward Outlook
For fiscal 2026, net sales decreased 5% to $6.72 billion, with organic sales down 8%. Diluted EPS fell 26% to $4.81 from $6.52. Operating cash flow declined 38% to $612 million, primarily due to the Glad Venture Agreement termination payment (8-K filing, 2026-08-03).
Looking to fiscal 2027, Clorox expects net sales growth of 13% to 14%, including about 9.5 points from the GOJO acquisition. Organic sales are projected to increase 3.5% to 4.5%, benefiting from lapping the prior year's ERP-related inventory drawdown. Diluted EPS is expected between $5.41 and $5.71, up 12% to 19%, while adjusted EPS is forecast between $5.70 and $6.00, representing growth of 3% to 8% (8-K filing, 2026-08-03).
"Our fourth-quarter results were in line with our expectations and reflect disciplined execution in a dynamic environment," said Chair and CEO Linda Rendle, noting that fiscal 2026 investments in brands, capabilities, and the completed U.S. ERP implementation have "strengthened our foundation" for future growth (8-K filing, 2026-08-03).
According to MarginX data, recent insider activity includes tax withholding transactions by executives Nina Barton (1,681 shares) and Chris T. Hyder (277 shares), alongside a 288.1391-share award to Stephanie Plaines.
This article was generated by MarginX from the 8-K filing on 2026-08-03. It is not investment advice.